Open AccessStem cell therapy in inflammatory bowel disease
Author(s) -
Welmoed K. van Deen,
Angelos Oikonomopoulos,
Daniël W. Hommes
Publication year - 2013
Publication title -
current opinion in gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.165
H-Index - 83
eISSN - 1531-7056
pISSN - 0267-1379
DOI - 10.1097/mog.0b013e328361f763
Subject(s) - medicine , stem cell , mesenchymal stem cell , stem cell therapy , inflammatory bowel disease , hematopoietic stem cell transplantation , cell therapy , transplantation , adverse effect , clinical trial , crohn's disease , disease , intensive care medicine , immunology , pathology , genetics , biology
Stem cell therapy has emerged as a promising therapeutic strategy for inflammatory bowel diseases (IBDs). Currently, stem cell therapy is not part of the standard of care and is usually only performed as a part of clinical trials. In this review, clinical results, proposed underlying mechanisms, and future research directions will be discussed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom